<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Alan Interactive Memo ‚Äî Proplace</title>
  <style>
:root { --bg-app: #f8fafc; --text-main: #1e293b; --yellow-menu: #FEF9C3; --green-menu: #DCFCE7; --grey-menu: #F1F5F9; }
body { font-family: 'Segoe UI', system-ui, sans-serif; background: var(--bg-app); color: var(--text-main); margin: 0; display: flex; }
html { scroll-behavior: smooth; }
a { color: #2563eb; text-decoration: none; }
a:hover { text-decoration: underline; }

/* TYPOGRAPHY */
h1, h2, h3, h4 { margin-top: 1.5em; margin-bottom: 0.5em; line-height: 1.2; color: #0f172a; }
h1 { font-size: 2.2em; font-weight: 800; margin-bottom: 5px; margin-top: 5px; }
h2 { font-size: 1.1em; font-weight: 400; color: #64748b; margin-top: 0; margin-bottom: 40px; }
h3 { font-size: 1.5em; border-bottom: 2px solid #e2e8f0; padding-bottom: 10px; margin-bottom: 20px; }
h4 { font-size: 1.1em; color: #475569; margin-top: 1em; text-transform: uppercase; letter-spacing: 0.5px; }
p { margin-top: 0; margin-bottom: 1em; line-height: 1.6; color: #334155; }
ul { margin-top: 0; margin-bottom: 1em; padding-left: 20px; }
li { margin-bottom: 0.5em; line-height: 1.6; }

/* LAYOUT & SIDEBAR */
.main-wrapper { display: flex; width: 100%; }
.sidebar { width: 300px; height: 100vh; position: sticky; top: 0; overflow-y: auto; border-right: 1px solid #e2e8f0; background: #fff; padding: 25px 0; flex-shrink: 0; z-index: 1000; display: flex; flex-direction: column; }
/* CONTENT AREA PADDING (FIXED) */
.content-area { flex: 1; padding: 20px 20px; width: 100%; min-width: 0; max-width: 1600px; margin: 0 auto; box-sizing: border-box; }

/* HEADER TAGS */
.header-tags { display: flex; flex-wrap: wrap; gap: 5px; margin-bottom: 5px; }

/* MOBILE NAV & RESPONSIVE GRID */
@media (max-width: 1000px) {
    body { flex-direction: column; }
    .main-wrapper { flex-direction: column; }
    .sidebar { width: 100%; height: auto; position: relative; border-right: none; border-bottom: 1px solid #e2e8f0; padding: 15px; display: block; overflow-x: hidden; }
    .meta-block { display: none; }
    /* Force top data to be visible on mobile if moved out of meta-block */
    .sb-top-data { display: flex; flex-wrap: wrap; gap: 8px; margin-bottom: 10px; } 
    
    .nav-item { display: block; padding: 10px 15px; border-left: 4px solid transparent; border-bottom: 1px solid #f1f5f9; margin: 0; }
    .content-area { padding: 20px; width: 100%; box-sizing: border-box; }
    
    /* FORCE SINGLE COLUMN STACK FOR MOBILE */
    .battlefield-grid { display: flex !important; flex-direction: column !important; width: 100%; gap: 15px; }
    .stage-desc-grid, .swot-grid-small, .split-container { display: flex; flex-direction: column; width: 100%; }
    
    .img-col { position: static; width: 100%; }
    /* Actor card full width override */
    .actor-card { width: 100% !important; margin-bottom: 15px; border-left-width: 4px; box-sizing: border-box; }
    /* Responsive Table Wrapper */
    .table-container { display: block; width: 100%; overflow-x: auto; -webkit-overflow-scrolling: touch; }
    .synergies-table, .vc-desc-table { min-width: 600px; } /* Force scroll on small screens */
}

/* SIDEBAR META BLOCK & CONTACT */
.meta-block { padding: 0 25px 25px; border-bottom: 1px solid #e2e8f0; margin-bottom: 15px; }
.sb-top-data { font-size: 0.85em; color: #475569; margin-bottom: 10px; line-height: 1.5; border-bottom: 1px solid #f1f5f9; padding-bottom: 10px; }
.sb-label-row { display: flex; flex-wrap: wrap; gap: 5px; margin-bottom: 5px; }
.sb-tag { background: #f1f5f9; padding: 2px 6px; border-radius: 4px; font-weight: 600; font-size: 0.9em; }
.sb-score { color: white; padding: 2px 6px; border-radius: 4px; font-weight: 700; font-size: 0.9em; }
.score-green { background: #16a34a; } .score-yellow { background: #ca8a04; } .score-red { background: #dc2626; }

.contact-row { font-size: 0.9em; color: #475569; margin-bottom: 15px; display: flex; flex-direction: column; gap: 5px; }
.contact-item { display: flex; align-items: center; gap: 8px; text-decoration: none; color: #334155; font-weight: 500; }
.contact-item:hover { color: #2563eb; }
.keyword-chips { display: flex; flex-wrap: wrap; gap: 6px; margin-top: 10px; }
.k-chip { background: #f1f5f9; color: #475569; padding: 4px 10px; border-radius: 12px; font-size: 0.8em; font-weight: 600; }

.meta-h3 { margin: 10px 0 5px 0; font-size: 1.4em; font-weight: 800; color: #1e293b; }
.meta-tagline { font-style: italic; color: #64748b; font-size: 0.9em; margin: 0 0 15px 0; display: block; }
.meta-market { font-weight: 600; color: #475569; font-size: 0.9em; margin-bottom: 15px; display: block; }

/* MENU ITEMS */
.nav-item { display: block; padding: 10px 25px; text-decoration: none; color: #475569; font-weight: 600; font-size: 0.9em; border-left: 4px solid transparent; transition: all 0.2s; margin-bottom: 2px; }
.nav-item:hover { background: rgba(0,0,0,0.05); color: #0f172a; border-left-color: #94a3b8; }
.bg-yellow { background: var(--yellow-menu); }
.bg-green { background: var(--green-menu); }
.bg-grey { background: var(--grey-menu); }

/* CTA BUTTON (Sidebar) */
.cta-btn { display: block; margin: 20px 25px 10px 25px; padding: 12px; background-color: #1e293b; color: #fff; text-align: center; border-radius: 6px; font-weight: 700; font-size: 0.9em; text-decoration: none; transition: background 0.2s; }
.cta-btn:hover { background-color: #334155; text-decoration: none; }
.promo-text { display: block; margin: 0 25px 20px; font-size: 0.8em; color: #64748b; text-align: center; font-style: italic; }

/* SPLIT LAYOUT & STICKY IMAGES */
.split-container { display: flex; gap: 40px; align-items: flex-start; margin-bottom: 50px; position: relative; }
.text-col { flex: 1; font-size: 1.05em; line-height: 1.7; color: #334155; }
.img-col { flex: 1; position: sticky; top: 20px; align-self: flex-start; }
.sticky-img { width: 100%; border-radius: 8px; box-shadow: 0 4px 12px rgba(0,0,0,0.08); border: 1px solid #e2e8f0; }

/* BATTLEFIELD & ACTOR CARDS */
.battlefield-grid { display: grid; grid-template-columns: repeat(6, 1fr); gap: 15px; width: 100%; margin-bottom: 40px; }
.battlefield-col { display: flex; flex-direction: column; gap: 10px; }
.actor-card { background: #fff; border: 1px solid #cbd5e0; border-radius: 6px; margin-bottom: 10px; overflow: hidden; font-size: 0.9em; border-left-width: 4px; }
/* POSTURE BORDER COLORS */
.border-hunter { border-left-color: #dc2626 !important; } 
.border-hunted { border-left-color: #ca8a04 !important; } 
.border-fortress { border-left-color: #2563eb !important; } 
.border-opportunistic { border-left-color: #16a34a !important; } 

/* SCENARIO CARD BEAUTIFICATION */
details { background: #fff; border: 1px solid #e2e8f0; border-radius: 8px; margin-bottom: 15px; padding: 0; box-shadow: 0 2px 4px rgba(0,0,0,0.03); transition: all 0.2s ease; }
details:hover { box-shadow: 0 4px 8px rgba(0,0,0,0.06); border-color: #cbd5e1; }
details[open] { background: #f8fafc; border-color: #94a3b8; }

.actor-card summary, .scen-header, details > summary { padding: 15px; cursor: pointer; font-weight: 500; list-style: none; display: flex; justify-content: space-between; align-items: flex-start; outline: none; }
details > summary::-webkit-details-marker { display: none; }

/* Custom + Icon */
.actor-card summary::after, .scen-header::after, details > summary::after { content: "+"; font-size: 1.4em; font-weight: 300; color: #94a3b8; transition: transform 0.2s; margin-left: 15px; line-height: 1; }
.actor-card[open] summary::after, details[open] > summary::after { content: "‚àí"; color: #475569; font-weight: 500; }

.actor-header-flex { display: flex; justify-content: space-between; align-items: center; flex: 1; }
.actor-right-labels { display: flex; gap: 8px; align-items: center; }
.label-tier { background: #f1f5f9; color: #475569; padding: 2px 6px; border-radius: 4px; font-size: 0.8em; }
.label-cap { background: #dcfce7; color: #166534; padding: 2px 6px; border-radius: 4px; font-size: 0.8em; border: 1px solid #bbf7d0; }

.actor-body { padding: 10px; border-top: 1px solid #f1f5f9; }
.meta-row { display: flex; align-items: center; gap: 6px; margin-bottom: 4px; color: #475569; font-size: 0.85em; }
.ws-box { background: #fffbeb; border: 1px solid #fef3c7; padding: 10px; border-radius: 6px; margin-bottom: 10px; }
.ws-link { color: #d97706; text-decoration: underline; font-weight: 600; cursor: pointer; }
.swot-grid-small { display: grid; grid-template-columns: 1fr 1fr; gap: 5px; margin-bottom: 10px; }
.sg-box { padding: 8px; border-radius: 4px; font-size: 1em; } 
.s-green { background: #dcfce7; color: #166534; } .s-red { background: #fee2e2; color: #991b1b; } .s-blue { background: #dbeafe; color: #1e40af; } .s-yellow { background: #fef9c3; color: #854d0e; }
.strat-inv-box { background: #f3e8ff; border: 1px solid #e9d5ff; padding: 10px; border-radius: 6px; margin-top: 10px; font-size: 0.85em; color: #6b21a8; }

/* SCENARIO LOGIC GRID */
.scen-logic-grid { display: flex; flex-wrap: wrap; gap: 8px; margin-top: 10px; width: 100%; }
.logic-tag { font-size: 0.75em; background: #f1f5f9; padding: 4px 10px; border-radius: 20px; border: 1px solid #e2e8f0; font-weight: 600; color: #475569; display: inline-block; }
.scen-summary-text { font-weight: 400; color: #334155; font-size: 1.05em; line-height: 1.5; }

/* SYNERGIES TABLE */
.synergies-table { width: 100%; border-collapse: collapse; margin-bottom: 20px; font-size: 0.9em; table-layout: fixed; }
.synergies-table th { background: #f1f5f9; padding: 10px; text-align: left; border-bottom: 2px solid #cbd5e1; }
.synergies-table td { padding: 10px; border-bottom: 1px solid #e2e8f0; vertical-align: top; word-wrap: break-word; }
.synergies-table tr:nth-child(even) { background: #f8fafc; }
.synergies-total-row { background: #f0fdf4 !important; font-weight: 700; border-top: 2px solid #bbf7d0; }
/* SYNERGY LEGEND: STANDARD STYLE */
.synergies-legend { background: transparent; padding: 0; border: none; font-size: 1em; color: #334155; }

/* Wide Summary Column */
.col-summary { width: 65% !important; }
.col-normal { width: 10%; }

/* SOURCES & FOOTER */
.dotted-line { border: none; border-top: 2px dashed #cbd5e0; margin: 30px 0; }
.source-list { font-size: 0.9em; color: #64748b; line-height: 1.6; }
.final-footer { margin-top: 60px; padding: 20px; text-align: center; border-top: 1px solid #e2e8f0; color: #94a3b8; font-size: 0.9em; }
  </style>
</head>
<body>
  <div class="main-wrapper">

    <!-- SIDEBAR -->
    <aside class="sidebar" aria-label="Sidebar navigation">
      <!-- Top block (visible on mobile) -->
      <div class="sb-top-data" style="padding:0 25px 10px;">
        <div class="sb-label-row" style="width:100%; align-items:center;">
          <span class="sb-score score-green">94</span>
          <span class="sb-tag">France</span>
          <span class="sb-tag">Series E+</span>
          <span class="sb-tag">Both</span>
        </div>
      </div>

      <!-- Company Name -->
      <div style="padding: 0 25px;">
        <h3 class="meta-h3">Alan</h3>
        <span class="meta-tagline">Comprehensive health partner that prevents, ensures, and supports daily health needs through integrated insurance and wellness.</span>
        <div class="meta-market">HealthTech &amp; Digital Health</div>
      </div>

      <!-- Contact Info & Keywords -->
      <div style="padding: 0 25px 15px;">
        <div class="contact-row">
          <div class="contact-item">üë§ Jean-Charles Samuelian-Werve</div>
          <a class="contact-item" href="https://linkedin.com/in/jcsamuelian" target="_blank">üîó LinkedIn</a>
          <a class="contact-item" href="mailto:charles@alan.com">‚úâÔ∏è charles@alan.com</a>
          <a class="contact-item" href="#" aria-disabled="true">‚òéÔ∏è No phone listed</a>
        </div>
        <div class="keyword-chips">
          <span class="k-chip">HealthTech &amp; Digital Health</span>
          <span class="k-chip">InsurTech</span>
          <span class="k-chip">FinTech</span>
          <span class="k-chip">SMB</span>
          <span class="k-chip">Mid-Market</span>
          <span class="k-chip">Enterprise</span>
          <span class="k-chip">B2C</span>
          <span class="k-chip">Government &amp; Public Sector</span>
          <span class="k-chip">B2B</span>
          <span class="k-chip">Subscription (SaaS/Recurring)</span>
          <span class="k-chip">Enterprise Sales</span>
          <span class="k-chip">SaaS</span>
          <span class="k-chip">Platform</span>
          <span class="k-chip">AI / ML</span>
        </div>
      </div>

      <!-- Menu -->
      <nav style="padding-top:10px;">
        <!-- Yellow group -->
        <a class="nav-item bg-yellow" href="#market">Market</a>
        <a class="nav-item bg-yellow" href="#value-chain">Value chain</a>
        <a class="nav-item bg-yellow" href="#competition">Competition</a>
        <a class="nav-item bg-yellow" href="#market-study">Market study</a>
        <a class="nav-item bg-yellow" href="#strategic-scenarios">Strategic scenarios</a>
        <a class="nav-item bg-yellow" href="#synergies">Synergies</a>

        <!-- Green group -->
        <a class="nav-item bg-green" href="#value-prop">Value proposition</a>
        <a class="nav-item bg-green" href="#product">Product</a>
        <a class="nav-item bg-green" href="#business-model">Business model</a>
        <a class="nav-item bg-green" href="#team">Team</a>
        <a class="nav-item bg-green" href="#ceo">CEO</a>
        <a class="nav-item bg-green" href="#company-summary">Company summary</a>
        <a class="nav-item bg-green" href="#swot">SWOT analysis</a>
        <a class="nav-item bg-green" href="#action-plan">Action plan</a>

        <!-- Grey group -->
        <a class="nav-item bg-grey" href="#conviction">Conviction</a>
        <a class="nav-item bg-grey" href="#sources">Sources</a>
      </nav>

      <!-- CTA -->
      <a class="cta-btn" href="https://forms.proplace.co/meet" target="_blank">Schedule a strategy call</a>
      <div class="promo-text">
        <em><a href="https://www.proplace.co" target="_blank" style="color:inherit; text-decoration: none;">Get AI companies studied in depth every day in your inbox</a></em>
      </div>
    </aside>

    <!-- CONTENT AREA -->
    <main class="content-area">
      <!-- STEP 2: Header Tags (above title) -->
      <div class="header-tags">
        <span class="sb-score score-green">94</span>
        <span class="sb-tag">France</span>
        <span class="sb-tag">Series E+</span>
        <span class="sb-tag">Both</span>
      </div>

      <h1>Alan Interactive Memo</h1>
      <h2>HealthTech &amp; Digital Health &gt; Integrated Digital Health Insurance SaaS</h2>
      <p style="font-style:italic; margin-top:-8px;">Digital integrated health insurance and wellness platforms for SMEs, self-employed, and retirees in Europe with automated HR and preventive care.</p>

      <!-- Completeness counts -->
      <p style="font-weight:600; color:#475569;">
        Rendered items: Actors (32) ¬∑ Strategic scenarios (15) ¬∑ Competitors (17) ¬∑ Sources (20)
      </p>

      <!-- STEP 3: MARKET (Grouped Sticky) -->
      <section id="market">
        <div class="split-container">
          <div class="text-col">
            <h3>Market sizing</h3>

            <p>Top-Down Market Analysis (Funnel Approach)</p>
            <p>Total Addressable Market (TAM): $148.16B</p>
            <p>Perimeter: Digital Insurance Platform market revenue, encompassing cloud-based, platform-oriented insurance technology activity, including health insurance SaaS (Global, 2025).</p>
            <p>Source Data: <a href="https://www.mordorintelligence.com/industry-reports/digital-insurance-platform-market?utm_source=openai" target="_blank">Mordor Intelligence - Digital Insurance Platform Market Report</a>.</p>

            <p>Serviceable Available Market (SAM): $8.75B</p>
            <p>Perimeter: Europe‚Äôs share of global Healthcare SaaS market, including software for health IT, payer/insurer tech, and care management, used as a proxy for integrated health insurance SaaS components (Europe, 2024).</p>
            <p>Source Verification: <a href="https://www.cognitivemarketresearch.com/healthcare-saas-market-report?utm_source=openai" target="_blank">Cognitive Market Research - Healthcare SaaS Market Report</a>.</p>

            <p>Serviceable Obtainable Market (SOM): $262.5M</p>
            <p>Perimeter: Realistic 3% market share of SAM for an early entrant; logic based on competitive landscape and penetration assumptions.</p>

            <p style="margin-top:12px;">Bottom-Up Market Analysis (Calculated Approach)</p>
            <p>This approach multiplies validated potential customers by average price assumptions to estimate market size.</p>
            <p>Customer Segment (Volume): 100,000 (SMEs 100‚Äì999 employees, self-employed, retirees; buyers include insurers, employers, TPAs).</p>
            <p>Unit Economics (Average Price): $50,000 ARPU (annual per organization, tiered SaaS pricing midpoint).</p>
            <p>Calculated Result (Bottom-up SAM proxy): $5B</p>
            <p>Sources referenced: <a href="https://market.us/report/digital-health-insurance-market/?utm_source=openai" target="_blank">Market.us - Digital Health Insurance Market Report</a>, <a href="https://fastercapital.com/content/Unit-economics-for-healthtech-operation--Healthy-Margins--How-Unit-Economics-Drive-HealthTech-Success.html?utm_source=openai" target="_blank">FasterCapital - Unit Economics</a>.</p>

            <h3>Market Trends</h3>
            <p>Market intelligence indicates a Europe SME insurtech platform surge driven by cloud-native adoption, integrated preventive care, and demand for automated HR/benefits workflows.</p>
            <p>Key points:</p>
            <ul>
              <li>Structural shift toward digital-first, GDPR-compliant platforms for SMEs, self-employed, and retirees. (<a href="https://market.us/report/digital-health-insurance-market/?utm_source=openai" target="_blank">market.us</a>)</li>
              <li>Velocity: Global digital insurance platform TAM estimated at $148.16B (2025) with ~7% CAGR to 2030; European healthcare SaaS SAM around $8.75B (2024) with higher growth proxies. (<a href="https://www.mordorintelligence.com/industry-reports/digital-insurance-platform-market?utm_source=openai" target="_blank">Mordor</a>, <a href="https://www.cognitivemarketresearch.com/healthcare-saas-market-report?utm_source=openai" target="_blank">Cognitive</a>)</li>
              <li>Value-chain control point: Policy Administration &amp; Underwriting is a strategic bottleneck with high margin potential and defensibility.</li>
              <li>Unit economics favor upstream/midstream stages due to software scaling and pricing power; typical SaaS gross margins cited by industry analysis. (<a href="https://cfoproanalytics.com/cfo-wiki/saas/gross-margin-targets-for-saas-companies/?utm_source=openai" target="_blank">CFO Pro Analytics</a>)</li>
            </ul>
          </div>

          <div class="img-col">
            <img class="sticky-img" src="https://placid-fra.fra1.digitaloceanspaces.com/production/rest-images/9e7podoyeqhi9/int-3423df77cf96fedb324a230d92dbdf03-htjyb662.jpg" alt="Market top-down image" />
            <div style="height:18px"></div>
            <img class="sticky-img" src="https://placid-fra.fra1.digitaloceanspaces.com/production/rest-images/9e7podoyeqhi9/int-b367257f257b8511d0ffb554c29967a4-ivpzsvpn.jpg" alt="Market bottom-up image" />
          </div>
        </div>
      </section>

      <!-- STEP 4: VALUE CHAIN (Grouped Sticky) -->
      <section id="value-chain">
        <div class="split-container">
          <div class="text-col">
            <h3>Value chain stages description</h3>
            <p>The integrated digital health insurance value chain spans upstream platform strategy and data foundation, through policy administration and underwriting, claims, provider network/ preventive care integration, to downstream member engagement and HR/service delivery. Each stage offers distinct margin, defensibility and growth characteristics.</p>

            <h3>Top 3 Value chain stage</h3>
            <p>Rank 1: Stage [3] - Policy Administration &amp; Underwriting ‚Äî Strategic Score: 7.5. Rationale: strong defensibility from actuarial IP, high margin potential from fixed-cost software automation, and direct access to premium pricing.</p>
            <p>Rank 2: Stage [1] - Platform Development &amp; Strategy ‚Äî Strategic Score: 7.2. Rationale: upstream control enables differentiation and high margins through product-led platform development tailored for European SME needs.</p>
            <p>Rank 3: Stage [2] - Data Foundation &amp; Interoperability ‚Äî Strategic Score: 6.9. Rationale: high defensibility from data moats, regulatory barriers and interoperability expertise (HL7/FHIR), essential for advanced underwriting and personalization.</p>

            <h3>Companies sorted by value chain stage specialization (battlefield)</h3>

            <h4>Legends</h4>
            <ul>
              <li><strong>Tiers</strong>: T1 = Global Giant; T2 = Large; T4 = ScaleUp; Unknown = not specified.</li>
              <li><strong>Capacity (cap)</strong>: Numerical proxy of relative capacity shown in the dataset (higher = more capacity).</li>
              <li><strong>Posture</strong>: 'Hunter' (active acquirer), 'Hunted' (target), 'Fortress' (defensive incumbent), 'Opportunistic' (acquiring/growing), 'Distressed' (vulnerable).</li>
            </ul>

            <div class="battlefield-grid">
              <!-- Column headers -->
              <div class="battlefield-col">
                <h4>Platform Development &amp; Strategy<br/>(Stage 1 ‚Äî 3 actors)</h4>

                <!-- Oracle Health -->
                <details class="actor-card border-hunted">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Oracle Health</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Country: Unknown ¬∑ Tier: Unknown ¬∑ Capacity: 0</p>
                    <p>Platform strategy specialist listed as a specialized company for Stage 1 in value chain analysis.</p>
                    <p>Founding: Unknown ¬∑ Funding: Unknown ¬∑ Investors: Unknown</p>
                    <p>Website: Unknown</p>
                    <p>Source: Value chain analysis (full response text)</p>
                  </div>
                </details>

                <!-- Guidewire -->
                <details class="actor-card border-hunted">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Guidewire</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Country: Unknown ¬∑ Tier: Unknown ¬∑ Capacity: 0</p>
                    <p>Policy platform specialist listed as a specialized company for Stage 1 in value chain analysis.</p>
                    <p>Founding: Unknown ¬∑ Funding: Unknown ¬∑ Investors: Unknown</p>
                    <p>Website: Unknown</p>
                    <p>Source: Value chain analysis (full response text)</p>
                  </div>
                </details>

                <!-- SAP -->
                <details class="actor-card border-fortress">
                  <summary>
                    <div class="actor-header-flex">
                      <div>SAP</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Country: Unknown ¬∑ Tier: Unknown ¬∑ Capacity: 0</p>
                    <p>Listed as a specialized company (analytics) for Stage 1 in value chain analysis.</p>
                    <p>Website: <a href="https://www.sap.com" target="_blank">sap.com</a></p>
                    <p>Source: Value chain analysis (full response text)</p>
                  </div>
                </details>

              </div>

              <div class="battlefield-col">
                <h4>Data Foundation &amp; Interoperability<br/>(Stage 2 ‚Äî 4 actors)</h4>

                <!-- CompuGroup Medical -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>CompuGroup Medical</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Data exchange specialist listed in Stage 2.</p>
                    <p>Website: Unknown ¬∑ Source: Value chain analysis (full response text)</p>
                  </div>
                </details>

                <!-- Verisk Analytics -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Verisk Analytics</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Website: <a href="https://www.verisk.com" target="_blank">verisk.com</a></p>
                    <p>Data foundation specialist listed in Stage 2.</p>
                    <p>Source: Value chain analysis (full response text)</p>
                  </div>
                </details>

                <!-- Sapiens -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Sapiens</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Website: <a href="https://www.sapiens.com" target="_blank">sapiens.com</a></p>
                    <p>Data exchange specialist listed in Stage 2.</p>
                  </div>
                </details>

                <!-- StoneRiver -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>StoneRiver</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Data exchange specialist listed in Stage 2.</p>
                    <p>Website: Unknown ¬∑ Source: Value chain analysis (full response text)</p>
                  </div>
                </details>

              </div>

              <div class="battlefield-col">
                <h4>Policy Administration &amp; Underwriting<br/>(Stage 3 ‚Äî 15 actors)</h4>

                <!-- Alan -->
                <details class="actor-card border-hunted">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Alan</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Country: FR ¬∑ Tier: T4_ScaleUp ¬∑ Capacity: 120 ¬∑ Diff Score: 8 ¬∑ Posture: Hunted</p>
                    <p>Comprehensive AI-driven platform streamlining claims to member engagement, specifically tailored for the European regulatory environment. Modular SaaS for digital health benefits.</p>
                    <p>Founding: 2018 ¬∑ Funding Round: Series F (2024-09-01)</p>
                    <p>Investors: Belfius Bank, OTPP via Teachers‚Äô Venture Growth, Temasek, Coatue, Lakestar</p>
                    <p>Website: <a href="https://alan.com" target="_blank">alan.com</a></p>
                    <p>Source: <a href="https://news.crunchbase.com/venture/french-company-alan-secures-54m-series-c-to-expand-digital-health-insurance-across-europe/?utm_source=openai" target="_blank">Crunchbase / news link</a></p>

                    <div>
                      <strong>Signals</strong>
                      <ul>
                        <li><a href="https://techcrunch.com/2024/09/20/health-insurance-startup-alan-reaches-45-billion-valuation-with-new-funding-round/?utm_source=openai" target="_blank">‚Ç¨173M Series F led by Belfius Bank (Sep 2024)</a></li>
                      </ul>
                    </div>

                    <div>
                      <strong>SWOT</strong>
                      <ul>
                        <li><strong>Strengths:</strong> Elite founder DNA; vertically integrated AI-driven platform; GDPR-compliant; ‚Ç¨173M Series F, ‚Ç¨60-70M ARR, 700+ team; high differentiation score.</li>
                        <li><strong>Weaknesses:</strong> Unprofitable to 2026 target; Europe-centric; opaque unit economics; nascent data moat; CEO-dominant structure.</li>
                        <li><strong>Opportunities:</strong> Potential exits/sales to AXA or Allianz; alliances with US players; distribution partnerships.</li>
                        <li><strong>Threats:</strong> Incumbent hunting by AXA/Allianz/Generali; regulatory volatility; macro downturn affecting SME budgets.</li>
                      </ul>
                    </div>

                    <div class="strat-inv-box">
                      <strong>Strategic signals / invitations</strong>
                      <ul>
                        <li>Hunter Bidding War: AXA vs Allianz for Alan's Stage 3 AI Platform</li>
                        <li>Gap Closure: AXA Acquires Alan to Fix Legacy Innovation</li>
                        <li>Cross-Atlantic Tech Share: Lemonade-Allianz AI Underwriting Partnership</li>
                      </ul>
                    </div>
                  </div>
                </details>

                <!-- Lemonade -->
                <details class="actor-card border-fortress">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Lemonade</div>
                      <div class="actor-right-labels"><span class="label-tier">T2_Large</span><span class="label-cap">Cap: 1000</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Country: USA ¬∑ Tier: T2_Large ¬∑ Capacity: 1000 ¬∑ Diff Score: 6 ¬∑ Posture: Fortress</p>
                    <p>Digital-first insurer leveraging AI and behavioral economics for underwriting and claims processing.</p>
                    <p>Founding: 2015 ¬∑ Funding: Series C (private 2017), IPO (2020)</p>
                    <p>Website: <a href="https://www.lemonade.com" target="_blank">lemonade.com</a></p>
                    <p>Source: <a href="https://news.crunchbase.com/venture/insurance-startup-lemonade-gets-sweeter-with-300m-infusion/?utm_source=openai" target="_blank">Crunchbase article</a></p>
                    <div>
                      <strong>Signals</strong>
                      <ul>
                        <li><a href="https://news.crunchbase.com/venture/insurance-startup-lemonade-gets-sweeter-with-300m-infusion/?utm_source=openai" target="_blank">No recent private rounds; public markets financing history</a></li>
                      </ul>
                    </div>
                  </div>
                </details>

                <!-- AXA -->
                <details class="actor-card border-hunter">
                  <summary>
                    <div class="actor-header-flex">
                      <div>AXA</div>
                      <div class="actor-right-labels"><span class="label-tier">T1_Global_Giant</span><span class="label-cap">Cap: 20000</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Tier: T1_Global_Giant ¬∑ Capacity: 20000 ¬∑ Diff Score: 6 ¬∑ Posture: Hunter</p>
                    <p>Major global insurer active in capital deployment and strategic investments, with large acquisition capacity.</p>
                    <p>Website: <a href="https://www.axa.com" target="_blank">axa.com</a></p>
                    <p>Source: <a href="https://www.axa.com/en/press/press-releases/axa-announces-the-placement-of-euro-750-million-senior-notes-due-2034?utm_source=openai" target="_blank">AXA press release</a></p>
                  </div>
                </details>

                <!-- Allianz -->
                <details class="actor-card border-hunter">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Allianz</div>
                      <div class="actor-right-labels"><span class="label-tier">T1_Global_Giant</span><span class="label-cap">Cap: 20000</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Tier: T1_Global_Giant ¬∑ Capacity: 20000 ¬∑ Diff Score: 6 ¬∑ Posture: Hunter</p>
                    <p>Global financial services company focused on insurance and asset management, active in acquisitions and strategic capital deployment.</p>
                    <p>Website: <a href="https://www.allianz.com" target="_blank">allianz.com</a></p>
                    <p>Source: <a href="https://www.allianz.com/en/mediacenter/news/media-releases/financials/241210-allianz-capital-markets-day.html?utm_source=openai" target="_blank">Allianz press</a></p>
                  </div>
                </details>

                <!-- Generali -->
                <details class="actor-card border-hunter">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Generali</div>
                      <div class="actor-right-labels"><span class="label-tier">T1_Global_Giant</span><span class="label-cap">Cap: 20000</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Tier: T1_Global_Giant ¬∑ Capacity: 20000 ¬∑ Diff Score: 6 ¬∑ Posture: Hunter</p>
                    <p>Global insurance and asset management group with strategic capital management programs.</p>
                    <p>Website: <a href="https://www.generali.com" target="_blank">generali.com</a></p>
                    <p>Source: <a href="https://presse.generali.fr/actualites/generali-lance-un-programme-de-rachat-dactions-pour-un-montant-maximal-de-500-millions-deuros-91506-a5035.html?utm_source=openai" target="_blank">Generali press</a></p>
                  </div>
                </details>

                <!-- Oscar Health -->
                <details class="actor-card border-fortress">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Oscar Health</div>
                      <div class="actor-right-labels"><span class="label-tier">T2_Large</span><span class="label-cap">Cap: 3000</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Tier: T2_Large ¬∑ Capacity: 3000 ¬∑ Diff Score: 6 ¬∑ Posture: Fortress</p>
                    <p>Public insurer with a digital platform for claims, clinical management and member experience.</p>
                    <p>Source: <a href="https://www.wsj.com/livecoverage/stock-market-today-dow-sp500-nasdaq-live-06-07-2024/card/oscar-health-bets-employers-want-workers-to-get-their-own-insurance-2JUO6RaxzVf7Mk5Fcg3Y?utm_source=openai" target="_blank">WSJ coverage</a></p>
                  </div>
                </details>

                <!-- Getsafe -->
                <details class="actor-card border-opportunistic">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Getsafe</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Country: DE ¬∑ Tier: T4_ScaleUp ¬∑ Capacity: 120 ¬∑ Diff Score: 7 ¬∑ Posture: Opportunistic</p>
                    <p>Mobile-first European insurtech focusing on flexible digital products and M&A to expand customer base.</p>
                    <p>Source: <a href="https://techcrunch.com/2024/01/17/getsafe-buys-deinestudienfinanzierung/?utm_source=openai" target="_blank">TechCrunch</a></p>
                  </div>
                </details>

                <!-- Coya -->
                <details class="actor-card border-fortress">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Coya</div>
                      <div class="actor-right-labels"><span class="label-tier">T2_Large</span><span class="label-cap">Cap: 28</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Country: DE ¬∑ Tier: T2_Large ¬∑ Capacity: 28 ¬∑ Diff Score: 4 ¬∑ Posture: Fortress</p>
                    <p>Digital-first P&amp;C insurer; parts acquired/rebranded in Europe.</p>
                    <p>Source: <a href="https://www.wsj.com/articles/healthier-capital-pockets-220-million-for-debut-healthtech-venture-fund-0a2816d4?utm_source=openai" target="_blank">WSJ</a></p>
                  </div>
                </details>

                <!-- Wefox -->
                <details class="actor-card border-hunted">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Wefox</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Tier: T4_ScaleUp ¬∑ Capacity: 120 ¬∑ Diff Score: 4 ¬∑ Posture: Distressed</p>
                    <p>Insurtech pivoting to asset-light MGA and distribution model; engaged in restructuring and refinancing.</p>
                    <p>Website: <a href="https://www.wefox.com" target="_blank">wefox.com</a></p>
                    <p>Source: <a href="https://www.wefox.com/press/wefox-successfully-secures-eur-151m-funding-to-support-new-strategy-with-focus-on-mga-business-and-smart-insurance-distribution/?utm_source=openai" target="_blank">wefox press</a></p>
                  </div>
                </details>

                <!-- Ottonova -->
                <details class="actor-card border-hunted">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Ottonova</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Tier: T4_ScaleUp ¬∑ Capacity: 120 ¬∑ Diff Score: 6 ¬∑ Posture: Hunted</p>
                    <p>German health insurtech with digital underwriting and engagement tools.</p>
                    <p>Source: <a href="https://beinsure.com/news/german-health-insurtech-ottonova-raises-e34-mn-in-series-f-financing/?utm_source=openai" target="_blank">BeInsure</a></p>
                  </div>
                </details>

                <!-- Sidecar Health -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Sidecar Health</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Employer-focused price-transparency healthcare app; $165M Series D in 2024.</p>
                    <p>Website: <a href="https://sidecarhealth.com" target="_blank">sidecarhealth.com</a></p>
                    <p>Source: <a href="https://sidecarhealth.com/press-releases/sidecar-health-selects-koch-disruptive-technologies-to-lead-165m-series-d-financing/?utm_source=openai" target="_blank">Sidecar Health press</a></p>
                  </div>
                </details>

                <!-- Aetna -->
                <details class="actor-card border-fortress">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Aetna (CVS Health)</div>
                      <div class="actor-right-labels"><span class="label-tier">T1_Global_Giant</span><span class="label-cap">Cap: 20000</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Subsidiary of CVS Health; enterprise-scale payer with integrated care platforms.</p>
                    <p>Source: <a href="https://investors.cvshealth.com/news/news-details/2025/CVS-HEALTH-CORPORATION-REPORTS-FOURTH-QUARTER-AND-FULL-YEAR-2024-RESULTS?utm_source=openai" target="_blank">CVS Health investor report</a></p>
                  </div>
                </details>

                <!-- HealthEdge -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>HealthEdge</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Policy-to-payment and claims systems specialist referenced in Stage 3/4.</p>
                    <p>Website: Unknown ¬∑ Source: Value chain analysis (full response text)</p>
                  </div>
                </details>

                <!-- Guidewire Cloud -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Guidewire Cloud</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Policy lifecycle specialist in Stage 3.</p>
                    <p>Website: <a href="https://www.guidewire.com" target="_blank">guidewire.com</a></p>
                  </div>
                </details>

                <!-- Oracle Health Insurance Cloud -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Oracle Health Insurance Cloud</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Referenced in Stage 3 as policy admin specialist.</p>
                    <p>Website: Unknown ¬∑ Source: Value chain analysis (full response text)</p>
                  </div>
                </details>

              </div>

              <div class="battlefield-col">
                <h4>Claims Adjudication &amp; Payments<br/>(Stage 4 ‚Äî 2 actors)</h4>

                <!-- Change Healthcare -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Change Healthcare</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">RCM specialist listed in Stage 4.</p>
                    <p>Website: <a href="https://www.changehealthcare.com" target="_blank">changehealthcare.com</a></p>
                  </div>
                </details>

                <!-- Waystar -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Waystar</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">RCM specialist listed in Stage 4.</p>
                    <p>Website: <a href="https://www.waystar.com" target="_blank">waystar.com</a></p>
                  </div>
                </details>

              </div>

              <div class="battlefield-col">
                <h4>Provider Network &amp; Preventive Care<br/>(Stage 5 ‚Äî 2 actors)</h4>

                <!-- Persivia -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Persivia</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Value-based care specialist for provider network integration.</p>
                    <p>Website: <a href="https://persivia.com" target="_blank">persivia.com</a></p>
                    <p>Source: <a href="https://persivia.com/2026/01/07/top-8-value-based-care-platforms-in-2026-compared/?utm_source=openai" target="_blank">Persivia article</a></p>
                  </div>
                </details>

                <!-- Salesforce Health Cloud -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Salesforce Health Cloud</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Care coordination and engagement specialist for provider networks.</p>
                    <p>Website: <a href="https://www.salesforce.com" target="_blank">salesforce.com</a></p>
                  </div>
                </details>

              </div>

              <div class="battlefield-col">
                <h4>Member Engagement &amp; HR/Service Delivery<br/>(Stage 6 ‚Äî 6 actors)</h4>

                <!-- Plum -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Plum</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Smart money app with ML-led product expansion; Stage 6 relevance for engagement/benefits.</p>
                    <p>Source: <a href="https://www.finsmes.com/2024/07/plum-raises-16m-in-series-b-funding.html?utm_source=openai" target="_blank">Finsmes</a></p>
                  </div>
                </details>

                <!-- Luko -->
                <details class="actor-card border-hunted">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Luko</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">FR ¬∑ Cap: 120 ¬∑ Posture: Hunted</p>
                    <p>Digital home insurance company evolved via strategic mergers; part of Admiral Group.</p>
                    <p>Source: <a href="https://www.wsj.com/articles/healthier-capital-pockets-220-million-for-debut-healthtech-venture-fund-0a2816d4?utm_source=openai" target="_blank">WSJ</a></p>
                  </div>
                </details>

                <!-- Hedvig -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Hedvig</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">SE ¬∑ Digital home insurance platform; bridge funding in 2024.</p>
                    <p>Source: <a href="https://nordic9.com/news/hedvig-in-a-sek-501-million-bridge-round-led-by-adelis-equity-in-sweden/?utm_source=openai" target="_blank">Nordic9</a></p>
                  </div>
                </details>

                <!-- Collective Health -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Collective Health</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Employer-focused benefits platform; Series F in 2021.</p>
                    <p>Website: <a href="https://collectivehealth.com" target="_blank">collectivehealth.com</a></p>
                    <p>Source: <a href="https://www.hcsc.com/newsroom/news-releases/2021/collective-health-280-million-funding?utm_source=openai" target="_blank">HCSC</a></p>
                  </div>
                </details>

                <!-- YuLife -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>YuLife</div>
                      <div class="actor-right-labels"><span class="label-tier">T4_ScaleUp</span><span class="label-cap">Cap: 120</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Gamified wellbeing-insurance platform; Series C in 2022.</p>
                    <p>Source: <a href="https://www.prnewswire.com/il/news-releases/yulife-raises-120m-series-c-round-led-by-dai-ichi-life-to-accelerate-global-expansion-301582061.html?utm_source=openai" target="_blank">PR Newswire</a></p>
                  </div>
                </details>

                <!-- Judi Health -->
                <details class="actor-card">
                  <summary>
                    <div class="actor-header-flex">
                      <div>Judi Health</div>
                      <div class="actor-right-labels"><span class="label-tier">Unknown</span><span class="label-cap">Cap: 0</span></div>
                    </div>
                  </summary>
                  <div class="actor-body">
                    <p class="meta-row">Member engagement / benefits specialist referenced in Stage 6.</p>
                    <p>Website: Unknown ¬∑ Source: Value chain analysis (full response text)</p>
                  </div>
                </details>

              </div>

            </div>
          </div>

          <div class="img-col">
            <img class="sticky-img" src="https://placid-fra.fra1.digitaloceanspaces.com/production/rest-images/9e7podoyeqhi9/int-98d02c830da8a8df570e7073712d24e6-e0iltapi.jpg" alt="Top 3 value chain image" />
          </div>
        </div>
      </section>

      <!-- STEP 5: COMPETITION (Grouped Sticky) -->
      <section id="competition">
        <div class="split-container">
          <div class="text-col">
            <h3>Competition overview</h3>
            <p>The competitive landscape segments players by capacity and posture: Predators (active hunters with high capacity), Aspirants (smaller active challengers), Giants (passive but deep-pocketed incumbents), and Potential Targets (low capacity/passive targets attractive to acquirers).</p>

            <h3 id="competitors">Competitors list</h3>

            <h4>Predators</h4>
            <p><strong>Lemonade</strong>: Digital-first insurer using AI for underwriting and claims. Website: <a href="https://www.lemonade.com" target="_blank">https://www.lemonade.com</a>. Source: <a href="https://www.wsj.com/articles/healthier-capital-pockets-220-million-for-debut-healthtech-venture-fund-0a2816d4?utm_source=openai" target="_blank">WSJ</a>.</p>
            <br>
            <p><strong>AXA</strong>: Major global insurer with active capital deployment. Website: <a href="https://www.axa.com" target="_blank">https://www.axa.com</a>. Source: <a href="https://www.axa.com/en/press/press-releases/axa-announces-the-placement-of-euro-750-million-senior-notes-due-2034?utm_source=openai" target="_blank">AXA press</a>.</p>
            <br>
            <p><strong>Allianz</strong>: Global insurer and asset manager, active in bolt-on acquisitions. Website: <a href="https://www.allianz.com" target="_blank">https://www.allianz.com</a>. Source: <a href="https://www.allianz.com/en/mediacenter/news/media-releases/financials/241210-allianz-capital-markets-day.html?utm_source=openai" target="_blank">Allianz press</a>.</p>
            <br>
            <p><strong>Generali</strong>: Global insurance group with strategic programs and capital management. Website: <a href="https://www.generali.com" target="_blank">https://www.generali.com</a>. Source: <a href="https://presse.generali.fr/actualites/generali-lance-un-programme-de-rachat-dactions-pour-un-montant-maximal-de-500-millions-deuros-91506-a5035.html?utm_source=openai" target="_blank">Generali press</a>.</p>
            <br>
            <p><strong>Oscar Health</strong>: Public insurer focused on digital member experience and employer engagement. Source: <a href="https://www.wsj.com/livecoverage/stock-market-today-dow-sp500-nasdaq-live-06-07-2024/card/oscar-health-bets-employers-want-workers-to-get-their-own-insurance-2JUO6RaxzVf7Mk5Fcg3Y?utm_source=openai" target="_blank">WSJ</a>.</p>

            <h4>Giants</h4>
            <p><strong>Aetna</strong>: Subsidiary of CVS Health, focusing on integrated care platforms. Source: <a href="https://investors.cvshealth.com/news/news-details/2025/CVS-HEALTH-CORPORATION-REPORTS-FOURTH-QUARTER-AND-FULL-YEAR-2024-RESULTS?utm_source=openai" target="_blank">CVS Health investor report</a>.</p>

            <h4>Aspirants</h4>
            <p><strong>Getsafe</strong>: Mobile-first European insurtech expanding via acquisitions. Source: <a href="https://www.wsj.com/articles/healthier-capital-pockets-220-million-for-debut-healthtech-venture-fund-0a2816d4?utm_source=openai" target="_blank">WSJ</a>.</p>
            <br>
            <p><strong>Coya</strong>: Digital-first P&amp;C insurer previously acquired/rebranded. Source: <a href="https://www.wsj.com/articles/healthier-capital-pockets-220-million-for-debut-healthtech-venture-fund-0a2816d4?utm_source=openai" target="_blank">WSJ</a>.</p>
            <br>
            <p><strong>Plum</strong>: Smart money app with expansion into engagement/benefits use cases. Source: <a href="https://www.finsmes.com/2024/07/plum-raises-16m-in-series-b-funding.html?utm_source=openai" target="_blank">Finsmes</a>.</p>

            <h4>Potential Targets</h4>
            <p><strong>Alan</strong>: Modular AI-driven health insurance and benefits platform. Website: <a href="https://alan.com" target="_blank">https://alan.com</a>. Source: <a href="https://news.crunchbase.com/venture/french-company-alan-secures-54m-series-c-to-expand-digital-health-insurance-across-europe/?utm_source=openai" target="_blank">Crunchbase</a>.</p>
            <br>
            <p><strong>Luko</strong>: Digital home insurer evolved via mergers; part of Admiral Group. Source: <a href="https://www.wsj.com/articles/healthier-capital-pockets-220-million-for-debut-healthtech-venture-fund-0a2816d4?utm_source=openai" target="_blank">WSJ</a>.</p>
            <br>
            <p><strong>Hedvig</strong>: Digital insurer with Nordic footprint and recent financing. Source: <a href="https://www.wsj.com/articles/healthier-capital-pockets-220-million-for-debut-healthtech-venture-fund-0a2816d4?utm_source=openai" target="_blank">WSJ</a>.</p>
            <br>
            <p><strong>Wefox</strong>: Pivoting to MGA and distribution; recent refinancing rounds. Website: <a href="https://www.wefox.com" target="_blank">https://www.wefox.com</a>. Source: <a href="https://www.wefox.com/press/wefox-successfully-secures-eur-151m-funding-to-support-new-strategy-with-focus-on-mga-business-and-smart-insurance-distribution/?utm_source=openai" target="_blank">wefox press</a>.</p>
            <br>
            <p><strong>Ottonova</strong>: German digital health insurer. Source: <a href="https://beinsure.com/news/german-health-insurtech-ottonova-raises-e34-mn-in-series-f-financing/?utm_source=openai" target="_blank">BeInsure</a>.</p>
            <br>
            <p><strong>Sidecar Health</strong>: Price-transparency employer health model. Website: <a href="https://sidecarhealth.com" target="_blank">sidecarhealth.com</a>. Source: <a href="https://sidecarhealth.com/press-releases/sidecar-health-selects-koch-disruptive-technologies-to-lead-165m-series-d-financing/?utm_source=openai" target="_blank">Sidecar Health press</a>.</p>
            <br>
            <p><strong>Collective Health</strong>: Platform for self-funded employers. Website: <a href="https://collectivehealth.com" target="_blank">collectivehealth.com</a>. Source: <a href="https://www.hcsc.com/newsroom/news-releases/2021/collective-health-280-million-funding?utm_source=openai" target="_blank">HCSC</a>.</p>
            <br>
            <p><strong>YuLife</strong>: Gamified wellbeing-insurance platform. Source: <a href="https://www.prnewswire.com/il/news-releases/yulife-raises-120m-series-c-round-led-by-dai-ichi-life-to-accelerate-global-expansion-301582061.html?utm_source=openai" target="_blank">PR Newswire</a>.</p>

          </div>

          <div class="img-col">
            <img class="sticky-img" src="https://placid-fra.fra1.digitaloceanspaces.com/production/rest-images/9e7podoyeqhi9/int-baeb7585377e2a8f858716d3884b9865-ei73rsfi.jpg" alt="Competition overview image" />
          </div>
        </div>
      </section>

      <!-- STEP 6: MARKET STUDY -->
      <section id="market-study">
        <div class="split-container">
          <div class="text-col">
            <h3>Market study</h3>
            <p><strong>Market Opportunity Score</strong></p>
            <p>Sector: HealthTech &amp; Digital Health &gt; Integrated Digital Health Insurance SaaS. Model: Both (Insurance + SaaS).</p>

            <p>IS IT AN ATTRACTIVE MARKET? (Dynamics): 88/100 √ó 25% = 22.0 points</p>
            <p>IS IT A WINNABLE MARKET? (Competition): 84/100 √ó 25% = 21.0 points</p>
            <p>IS IT A PENETRABLE MARKET? (GTM): 85/100 √ó 25% = 21.25 points</p>
            <p>IS IT A REWARDING MARKET? (Exits): 92/100 √ó 25% = 23.0 points</p>

            <p><strong>Total Market Attractivity Score:</strong> 87.25/100</p>

            <h4>Market definition</h4>
            <p>Digital integrated health insurance and wellness platforms for SMEs, self-employed, and retirees in Europe with automated HR and preventive care. These platforms transform health insurance into a vertically integrated health operating system and leverage large-scale SME adoption of digital benefits to automate HR and prevent health issues.</p>

            <h4>Market thesis & conviction</h4>
            <p>Market inflection: regulatory and digital adoption changes create a platform transition away from legacy systems. High conviction that timing and moat-building (data + regulatory licensing) enable a decisive founder-led platform to become system of record in this vertical.</p>

            <h4>Score highlights</h4>
            <ul>
              <li>Attractive market dynamics with TAM: $148.16B, SAM: $8.75B, SOM: $262.5M.</li>
              <li>Winnable market with fragmented incumbents and clear white space among SMEs.</li>
              <li>Penetrability supported by enterprise sales and PLG motions with $50k ARPU benchmarks.</li>
              <li>Rewarding exit environment with strong strategic buyer interest and healthy multiples.</li>
            </ul>
          </div>

          <div class="img-col">
            <img class="sticky-img" src="https://placid-fra.fra1.digitaloceanspaces.com/production/rest-images/9e7podoyeqhi9/int-51cb85777aeecc6866fbc2d0b8a30877-jfm3tma5.jpg" alt="Market study image" />
          </div>
        </div>
      </section>

      <!-- STEP 7: STRATEGIC SCENARIOS -->
      <section id="strategic-scenarios">
        <div class="split-container">
          <div class="text-col">
            <h3>Strategic scenarios</h3>
            <p>Total scenarios rendered: 15</p>

            <!-- Loop groups and scenarios -->
            <!-- Group 1 -->
            <h4>‚öîÔ∏è ACQUISITION BATTLES (HIGH CONFLICT)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Target: Alan - AXA and Allianz are in a bidding war for Alan's Policy Administration &amp; Underwriting AI platform, a high-stakes competition for leadership in this function. (Competing Actors: AXA, Allianz)</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: AXA, Allianz</span>
                    <span class="logic-tag">Target: Alan</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Hunter Bidding War: AXA vs Allianz for Alan's Stage 3 AI Platform</h4>
                <p><strong>Rationale:</strong> AXA and Allianz, both T1 hunters, have strong acquisition capacity and view Alan (highly differentiated Stage 3/6 platform) as a strategic bolt-on. Window: mid-term (6‚Äì18 months) given funding momentum and Alan‚Äôs private status.</p>
                <p><strong>Deal breaker:</strong> EU antitrust scrutiny and integration complexity between cloud-native Alan and incumbent stacks.</p>
                <p><strong>Synergy:</strong> Hard cost saving: bypass ‚Ç¨500M+ R&amp;D for underwriting engine. Soft revenue: bundling could unlock ‚Ç¨1B+ ARR in preventive care upsells.</p>
                <p><strong>Macro:</strong> Direct leverage of Europe SME insurtech surge; Stage 3 control point with high strategic value.</p>
                <p><strong>Priority:</strong> High Priority ¬∑ <strong>Timeline:</strong> MID-TERM</p>
                <p><strong>Confidence:</strong> 55 ‚Äî Data gaps on unit economics, CEO concentration and private status reduce certainty.</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨1,500,000,000 (Soft revenue ‚âà ‚Ç¨1,000,000,000 ¬∑ Hard cost ‚âà ‚Ç¨500,000,000)</p>
              </div>
            </details>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Target: Ottonova - Generali and AXA competing to acquire Ottonova for German market control. (Competing Actors: Generali, AXA)</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: Generali, AXA</span>
                    <span class="logic-tag">Target: Ottonova</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>German Health Play Race: Generali vs AXA for Ottonova</h4>
                <p><strong>Rationale:</strong> Hunters target Ottonova to secure German SME health platform presence; mid-term timeline tied to funding cycles.</p>
                <p><strong>Deal breaker:</strong> Break-even delays at Ottonova.</p>
                <p><strong>Synergy:</strong> Hard cost: acquire pre-break-even tech at discount.</p>
                <p><strong>Priority:</strong> High Priority ¬∑ <strong>Timeline:</strong> MID-TERM</p>
                <p><strong>Confidence:</strong> 65</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨10,000,000</p>
              </div>
            </details>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Target: Ottonova-like Assets - Allianz and Generali engaged in a resource war over similar German assets (Competing Actors: Allianz, Generali).</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: Allianz, Generali</span>
                    <span class="logic-tag">Contested Resource: German SME Health Platforms</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>German Turf War: Allianz vs Generali for Ottonova-like Assets</h4>
                <p><strong>Rationale:</strong> Giants stake a short-term push to secure German market control; regulatory caps possible.</p>
                <p><strong>Synergy:</strong> Soft revenue: market share lock-in.</p>
                <p><strong>Priority:</strong> High Priority ¬∑ <strong>Timeline:</strong> SHORT-TERM</p>
                <p><strong>Confidence:</strong> 80</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨50,000,000</p>
              </div>
            </details>

            <!-- Group 2 -->
            <h4>ü§ù INEVITABLE ALLIANCES (HIGH SYNERGY)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Alliance: Lemonade and Oscar Health - Sharing AI underwriting technology to expand health offerings and improve preventive care (Foci: US health expansion).</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: Lemonade, Alan</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Cross-Atlantic Tech Share: Lemonade-Allian AI Underwriting Partnership</h4>
                <p><strong>Rationale:</strong> Fortress Lemonade seeks Europe entry; alliance could address US/Europe gaps. Mid-term timeline for regulatory navigation.</p>
                <p><strong>Deal breaker:</strong> IP-sharing disputes and divergent product focus.</p>
                <p><strong>Synergy:</strong> Shared actuarial IP could target $100M ARR and reduce redundant R&amp;D by ~30% (estimated).</p>
                <p><strong>Priority:</strong> Medium Priority ¬∑ <strong>Timeline:</strong> MID-TERM</p>
                <p><strong>Confidence:</strong> 65</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨130,000,000</p>
              </div>
            </details>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Alliance: Oscar Health and Lemonade - Shared AI for US health expansion and product efficiency. (Actors: Oscar Health, Lemonade)</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: Oscar Health, Lemonade</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>US Fortress Alliance: Oscar-Lemonade Shared AI for Health Expansion</h4>
                <p><strong>Rationale:</strong> Twin Fortresses share R&amp;D to improve cost base and underwriting capabilities; long-term structural play.</p>
                <p><strong>Deal breaker:</strong> Strategic misalignment across companies.</p>
                <p><strong>Synergy:</strong> Joint R&amp;D halves development costs.</p>
                <p><strong>Priority:</strong> Medium Priority ¬∑ <strong>Timeline:</strong> LONG-TERM</p>
                <p><strong>Confidence:</strong> 90</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨50,000,000</p>
              </div>
            </details>

            <!-- Group 3 -->
            <h4>üóúÔ∏è SQUEEZE THREATS (REMOVING INTERMEDIARIES)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Threatened: Wefox - AXA and Getsafe circling Wefox assets due to distress and asset sales. (Attackers: AXA, Getsafe)</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Threatened: Wefox</span>
                    <span class="logic-tag">Attackers: AXA, Getsafe</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Distressed Fire-Sale Squeeze: AXA and Getsafe Circling Wefox Assets</h4>
                <p><strong>Rationale:</strong> Wefox‚Äôs restructuring and asset sales make it vulnerable to squeeze by Hunters and Opportunistic acquirers; short-term bankruptcy triggers possible.</p>
                <p><strong>Deal breaker:</strong> Asset quality and potential outbidding.</p>
                <p><strong>Synergy:</strong> Hard cost: consolidation savings ‚âà ‚Ç¨50M+</p>
                <p><strong>Priority:</strong> High Priority ¬∑ <strong>Timeline:</strong> SHORT-TERM</p>
                <p><strong>Confidence:</strong> 65</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨50,000,000</p>
              </div>
            </details>

            <!-- Group 4 -->
            <h4>‚õìÔ∏è DEPENDENCY RISKS (RELIANCE ON SUPPLIERS)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Dependent: YuLife / Plum - Plum relies on YuLife for gamified wellbeing and faces pressure from Generali. (Supplier: YuLife)</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Dependent: Plum</span>
                    <span class="logic-tag">Supplier: YuLife</span>
                    <span class="logic-tag">Competitor: Generali</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Stage 6 Squeeze: Plum Pressured on YuLife by Generali Hunters</h4>
                <p><strong>Rationale:</strong> Generali's acquisition pressure on YuLife could block Plum's engagement and rewards bundling; mid-term speculative risk.</p>
                <p><strong>Priority:</strong> Low Priority ¬∑ <strong>Timeline:</strong> MID-TERM</p>
                <p><strong>Confidence:</strong> 55</p>
              </div>
            </details>

            <!-- Group 5 -->
            <h4>üß© MARKET CONSOLIDATION (BUYING SMALLER PLAYERS)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Actor: Getsafe - consolidating distressed Europe insurtech assets (example: Luko's German portfolio acquisition).</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: Getsafe</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>ScaleUp Roll-Up: Getsafe Consolidating Distressed Europe Insurtech Assets</h4>
                <p><strong>Rationale:</strong> Getsafe uses roll-up to build MGA and portfolio scale; medium-term consolidation opportunity.</p>
                <p><strong>Synergy:</strong> Hard cost: portfolio integration savings (‚âà ‚Ç¨25M estimated).</p>
                <p><strong>Priority:</strong> Medium Priority ¬∑ <strong>Timeline:</strong> MID-TERM</p>
                <p><strong>Confidence:</strong> 65</p>
              </div>
            </details>

            <!-- Group 6 -->
            <h4>üï≥Ô∏è MISSED OPPORTUNITIES (GAPS)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Actor: AXA - acquiring Alan to close legacy innovation gap in SME underwriting (Solution: Alan).</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: AXA</span>
                    <span class="logic-tag">Solution: Alan</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Gap Closure: AXA Acquires Alan to Fix Legacy Innovation in SME Underwriting</h4>
                <p><strong>Rationale:</strong> AXA would fill product and underwriting gaps by acquiring Alan; short-term urgency due to Alan‚Äôs unprofitability and incumbent threats.</p>
                <p><strong>Deal breaker:</strong> Integration complexity and regulatory volatility.</p>
                <p><strong>Synergy:</strong> Hard cost saving: bypass internal build; soft revenue: SME bundling ARPU uplift.</p>
                <p><strong>Priority:</strong> High Priority ¬∑ <strong>Timeline:</strong> SHORT-TERM</p>
                <p><strong>Confidence:</strong> 30</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨350,000,000</p>
              </div>
            </details>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Actor: Allianz - bolt-on Hedvig to fill digital engagement gap in Nordic markets (Solution: Hedvig).</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: Allianz</span>
                    <span class="logic-tag">Solution: Hedvig</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Nordic Bolt-On: Allianz Fills Digital Engagement Gap with Hedvig</h4>
                <p><strong>Rationale:</strong> Allianz uses Hedvig to boost member engagement in Nordic markets; short-term due to subsidiary complexity.</p>
                <p><strong>Priority:</strong> Medium Priority ¬∑ <strong>Timeline:</strong> SHORT-TERM</p>
                <p><strong>Confidence:</strong> 50</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨20,000,000</p>
              </div>
            </details>

            <!-- Group 7 -->
            <h4>üìâ CHAIN REACTIONS (PREDICTED COUNTER-MOVES)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Threatened Actor: Wefox - AXA-Alan deal could force Getsafe to acquire Wefox, triggering a consolidation cascade.</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Threatened Actor: Wefox</span>
                    <span class="logic-tag">Response Move: Acquisition of Wefox</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Consolidation Domino: AXA-Alan Deal Forces Getsafe Wefox Grab</h4>
                <p><strong>Rationale:</strong> One major acquisition can trigger defensive acquisitions to secure complementary assets; short-term bidding urgency.</p>
                <p><strong>Priority:</strong> Medium Priority ¬∑ <strong>Timeline:</strong> SHORT-TERM</p>
                <p><strong>Confidence:</strong> 60</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨10,000,000</p>
              </div>
            </details>

            <!-- Group 8 -->
            <h4>‚ö†Ô∏è SYSTEMIC RISKS (MARKET FRAGILITY)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Risk Point: Coya - Alan controlling Stage 3 could displace commoditized players like Coya, creating systemic risk for low-diff incumbents.</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Controlling Actor: Alan</span>
                    <span class="logic-tag">Vulnerable Actors: Luko, Coya</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Stage 3 Bottleneck Risk: Alan Controls Displacement of Commoditized Players</h4>
                <p><strong>Rationale:</strong> Alan's Stage 3 IP can marginalize low-differentiation players; long-term structural risk.</p>
                <p><strong>Priority:</strong> High Priority ¬∑ <strong>Timeline:</strong> LONG-TERM</p>
                <p><strong>Confidence:</strong> 75</p>
              </div>
            </details>

            <!-- Group 9 -->
            <h4>üåÄ PLATFORM STRATEGIES (CONTROLLED ECOSYSTEMS)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Actor: AXA - Building SME super-platform via acquisitions (Alan + Luko) to control ecosystem and lock users.</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: AXA</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>SME Super-Platform: AXA Builds via Alan + Luko Acquisitions</h4>
                <p><strong>Rationale:</strong> Vertical stacking of Stage 3 and Stage 6 to create high-ARPU SME super-platform; mid-term integration risk and regulatory scrutiny.</p>
                <p><strong>Priority:</strong> High Priority ¬∑ <strong>Timeline:</strong> MID-TERM</p>
                <p><strong>Confidence:</strong> 55</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨100,000,000</p>
              </div>
            </details>

            <!-- Group 10 -->
            <h4>‚ö° HIDDEN SYNERGIES</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Synergies: Lemonade &amp; Oscar Health exploring undisclosed cross-underwriting synergies for enhanced predictive models and efficiencies.</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: Lemonade, Oscar Health</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Undisclosed AI Moat: Lemonade-Oscar Cross-Underwriting Synergy</h4>
                <p><strong>Rationale:</strong> Joint research and predictive model development may boost ARR and predictive power; long-term R&amp;D focus.</p>
                <p><strong>Priority:</strong> Low Priority ¬∑ <strong>Timeline:</strong> LONG-TERM</p>
                <p><strong>Confidence:</strong> 65</p>
                <p><strong>Estimated Financials:</strong> Total synergies ‚âà ‚Ç¨20,000,000</p>
              </div>
            </details>

            <!-- Group 11 -->
            <h4>üí£ THREATENED FORTRESSES (VULNERABLE ASSETS)</h4>

            <details>
              <summary>
                <div style="flex:1;">
                  <div class="scen-summary-text">Risk Point: Coya - Low cash and commoditization make Coya vulnerable to hunting/acquisition by larger incumbents.</div>
                  <div class="scen-logic-grid">
                    <span class="logic-tag">Actors: Coya</span>
                    <span class="logic-tag">Attackers: AXA</span>
                  </div>
                </div>
              </summary>
              <div style="padding:12px;">
                <h4>Low-Cash Siege: AXA Targets Vulnerable Coya Fortress</h4>
                <p><strong>Rationale:</strong> Coya's declining cash balance and low differentiation present opportunistic acquisition targets for Hunters.</p>
                <p><strong>Priority:</strong> Medium Priority ¬∑ <strong>Timeline:</strong> SHORT-TERM</p>
                <p><strong>Confidence:</strong> 75</p>
              </div>
            </details>

          </div>

          <div class="img-col">
            <img class="sticky-img" src="https://placid-fra.fra1.digitaloceanspaces.com/production/rest-images/9e7podoyeqhi9/int-1e8fdc2fd0ac7caaf8b20149a358a5d5-3uielu7o.jpg" alt="Scenarios map" />
          </div>
        </div>
      </section>

      <!-- STEP 8: SYNERGIES -->
      <section id="synergies">
        <h3>Synergy detailed table</h3>

        <div class="table-container">
          <table class="synergies-table" role="table" aria-label="Synergies detailed table">
            <thead>
              <tr>
                <th class="col-normal">Group Header</th>
                <th class="col-summary">Summary</th>
                <th class="col-normal">Actors</th>
                <th class="col-normal">Target</th>
                <th class="col-normal">Solution</th>
                <th class="col-normal">Threatened</th>
                <th class="col-normal">Attackers</th>
                <th class="col-normal">Targets</th>
                <th class="col-normal">Controlling Actor</th>
                <th class="col-normal">Vulnerable Actors</th>
                <th class="col-normal">Contested Resource</th>
                <th class="col-normal">Response Move</th>
                <th class="col-normal">Soft Revenue</th>
                <th class="col-normal">Hard Cost</th>
                <th class="col-normal">Scenario Total</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>‚öîÔ∏è ACQUISITION BATTLES (HIGH CONFLICT)</td>
                <td>Target: Alan - AXA and Allianz are in a bidding war for Alan's Policy Administration &amp; Underwriting AI platform...</td>
                <td>AXA, Allianz</td>
                <td>Alan</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>1,000,000,000</td>
                <td>500,000,000</td>
                <td>1,500,000,000</td>
              </tr>

              <tr>
                <td>üï≥Ô∏è MISSED OPPORTUNITIES (GAPS)</td>
                <td>Actor: AXA - AXA is acquiring Alan to address gaps in its legacy innovation within SME underwriting...</td>
                <td>AXA</td>
                <td></td>
                <td>Alan</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>50,000,000</td>
                <td>300,000,000</td>
                <td>350,000,000</td>
              </tr>

              <tr>
                <td>ü§ù INEVITABLE ALLIANCES (HIGH SYNERGY)</td>
                <td>Alliance: Lemonade and Oscar Health forming AI underwriting partnership (US health expansion; preventive care).</td>
                <td>Lemonade, Alan</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>100,000,000</td>
                <td>30,000,000</td>
                <td>130,000,000</td>
              </tr>

              <tr>
                <td>üåÄ PLATFORM STRATEGIES (CONTROLLED ECOSYSTEMS)</td>
                <td>Actor: AXA building SME super-platform through acquisitions (Alan + Luko) to control ecosystem.</td>
                <td>AXA</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>0</td>
                <td>100,000,000</td>
                <td>100,000,000</td>
              </tr>

              <tr>
                <td>üóúÔ∏è SQUEEZE THREATS (REMOVING INTERMEDIARIES)</td>
                <td>Threatened: Wefox - AXA and Getsafe circling Wefox assets due to distress and asset sales.</td>
                <td>AXA, Getsafe</td>
                <td></td>
                <td></td>
                <td>Wefox</td>
                <td>AXA, Getsafe</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>0</td>
                <td>50,000,000</td>
                <td>50,000,000</td>
              </tr>

              <tr>
                <td>‚öîÔ∏è ACQUISITION BATTLES (HIGH CONFLICT)</td>
                <td>Target: Ottonova-like Assets - Allianz and Generali engaged in a resource war over German assets.</td>
                <td>Allianz, Generali</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>German SME Health Platforms</td>
                <td></td>
                <td>50,000,000</td>
                <td>0</td>
                <td>50,000,000</td>
              </tr>

              <tr>
                <td>ü§ù INEVITABLE ALLIANCES (HIGH SYNERGY)</td>
                <td>Alliance: Lemonade and Oscar Health forming AI underwriting partnership (duplicate row for Oscar-Lemonade pairing).</td>
                <td>Oscar Health, Lemonade</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>0</td>
                <td>50,000,000</td>
                <td>50,000,000</td>
              </tr>

              <tr>
                <td>üß© MARKET CONSOLIDATION (BUYING SMALLER PLAYERS)</td>
                <td>Actor: Getsafe - consolidating distressed Europe insurtech assets, targeting Wefox and Luko.</td>
                <td>Getsafe</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>Wefox, Luko</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>0</td>
                <td>25,000,000</td>
                <td>25,000,000</td>
              </tr>

              <tr>
                <td>üï≥Ô∏è MISSED OPPORTUNITIES (GAPS)</td>
                <td>Actor: Allianz acquiring Hedvig to plug digital engagement gaps; Hedvig as a Nordic bolt-on.</td>
                <td>Allianz</td>
                <td></td>
                <td>Hedvig</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>20,000,000</td>
                <td>0</td>
                <td>20,000,000</td>
              </tr>

              <tr>
                <td>‚ö° HIDDEN SYNERGIES</td>
                <td>Lemonade and Oscar Health exploring undisclosed cross-underwriting synergies in Stage 3.</td>
                <td>Lemonade, Oscar Health</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>20,000,000</td>
                <td>0</td>
                <td>20,000,000</td>
              </tr>

              <tr>
                <td>‚öîÔ∏è ACQUISITION BATTLES (HIGH CONFLICT)</td>
                <td>Target: Ottonova - Generali and AXA competing for Ottonova.</td>
                <td>Generali, AXA</td>
                <td>Ottonova</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>0</td>
                <td>10,000,000</td>
                <td>10,000,000</td>
              </tr>

              <tr>
                <td>üìâ CHAIN REACTIONS (PREDICTED COUNTER-MOVES)</td>
                <td>Threatened Actor: Wefox - AXA-Alan deal may force Getsafe to acquire Wefox, triggering chain responses.</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>Wefox</td>
                <td>Acquisition of Wefox</td>
                <td></td>
                <td>0</td>
                <td>10,000,000</td>
                <td>10,000,000</td>
              </tr>

              <tr>
                <td>‚õìÔ∏è DEPENDENCY RISKS (RELIANCE ON SUPPLIERS)</td>
                <td>Dependent: YuLife - Plum depends on YuLife and faces Generali pressure (risk row).</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
              </tr>

              <tr>
                <td>‚ö†Ô∏è SYSTEMIC RISKS (MARKET FRAGILITY)</td>
                <td>Risk Point: Coya - Alan's Stage 3 dominance could displace commoditized players like Coya and Luko.</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>Alan</td>
                <td>Luko, Coya</td>
                <td></td>
                <td></td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
              </tr>

              <tr>
                <td>üí£ THREATENED FORTRESSES (VULNERABLE ASSETS)</td>
                <td>Risk Point: Coya - Low cash and commoditization make Coya vulnerable to Hunter acquisition.</td>
                <td>Coya</td>
                <td></td>
                <td></td>
                <td></td>
                <td>AXA</td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td></td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
              </tr>
            </tbody>
          </table>
        </div>

        <h3>Synergy legend</h3>
        <div class="split-container">
          <div class="text-col synergies-legend">
            <p><strong>Strategic Impact Summary</strong></p>
            <p>This table provides a comprehensive overview of strategic scenarios, grouped by theme and quantified by potential financial synergies. Each row maps scenario summaries to actors, roles (Target, Attacker), and estimated soft revenue / hard cost synergies. Values are conservatively estimated and sorted by scenario total.</p>

            <p><strong>Visual methodology</strong></p>
            <ul>
              <li>Players segmented by potential acquirers (Hunters) vs targets; scenarios emphasize Stage 3 (Policy Admin) scarcity and Stage 6 engagement opportunities.</li>
              <li>Financial columns present conservative synergies: Soft revenue (upsell/recurring ARR) and Hard cost (R&amp;D / integration savings).</li>
            </ul>

            <p><strong>Scenarios involving Alan (examples)</strong></p>
            <ul>
              <li>Alan as Target in bidding war (AXA vs Allianz).</li>
              <li>Alan as Solution for AXA's legacy gap.</li>
              <li>Alan as trigger for consolidation chain reactions (e.g., Getsafe and Wefox dynamics).</li>
            </ul>
          </div>

          <div class="img-col">
            <img class="sticky-img" src="https://placid-fra.fra1.digitaloceanspaces.com/production/rest-images/9e7podoyeqhi9/int-8fe707d39801393cd5b70e0fdf2581c2-4fnkqcws.jpg" alt="Synergies image" />
          </div>
        </div>
      </section>

      <!-- STEP 9: COMPANY ANALYSIS -->
      <section id="company-analysis">
        <div class="split-container">
          <div class="text-col">
            <h3 id="value-prop">Value Proposition</h3>
            <p>Alan positions itself as a comprehensive health partner that prevents, ensures, and supports daily health needs. It offers a single point of contact for health insurance, provident fund, and prevention services to simplify health management for businesses and individuals.</p>

            <h4 id="product">Product</h4>
            <p>Core solution: Integrated health insurance, provident fund management, and prevention delivered through an employer interface and member mobile app. Features include automated HR workflows, Alan Play prevention challenges, Alan Clinic teleconsultations, fast reimbursements, meditation and mental health resources, and a rewards program.</p>

            <h4 id="business-model">Business model</h4>
            <p>Primarily a SaaS + insurance model: subscription-based contracts with employers (per-employee pricing and premium insurance components), combined with insurance premia and add-on preventive services. Public plan and individual offerings exist.</p>

            <h4 id="team">Team</h4>
            <p>Company culture emphasizes efficiency, clarity, and customer-centric service. Public materials indicate a ~700-headcount organization with product, engineering, and operations teams supporting multi-country deployments.</p>

            <h4 id="ceo">CEO ‚Äî Jean-Charles Samuelian-Werve</h4>
            <p>Founder archetype: product-led founder with engineering and management background. Tenure: over 10 years at Alan; prior co-founder at Expliseat. Academic background: √âcole nationale des ponts et chauss√©es and Coll√®ge des Ing√©nieurs (MBA). Advisory role at Mistral AI suggests engagement with frontier technology.</p>

            <h4 id="company-summary">Company summary</h4>
            <p>Alan is a vertically integrated digital health insurer and benefits platform with strong product differentiation (Alan Clinic, Mo AI assistant), regulatory licensing in Europe, and enterprise-level wins including public sector contracts. Funding: ‚Ç¨173M Series F (Sep 2024) supporting international expansion and product development.</p>
          </div>

          <div class="img-col">
            <img class="sticky-img" src="https://placid-fra.fra1.digitaloceanspaces.com/production/rest-images/9e7podoyeqhi9/int-e75049ec54335ccdc10f771337fc764d-2uocczqj.jpg" alt="Company image" />
          </div>
        </div>
      </section>

      <!-- STEP 10: SWOT & ACTION PLAN -->
      <section id="swot">
        <h3>SWOT analysis</h3>
        <div class="swot-grid-small">
          <div class="sg-box s-green">
            <h4>Strengths</h4>
            <ul>
              <li>Elite founder DNA; product-led engineering background and long tenure.</li>
              <li>Vertically integrated platform: underwriting, care delivery, member engagement.</li>
              <li>Significant traction and scale: ‚Ç¨60‚Äì70M ARR, 700+ employees, ‚Ç¨173M Series F.</li>
            </ul>
          </div>
          <div class="sg-box s-red">
            <h4>Weaknesses</h4>
            <ul>
              <li>Unprofitable to planned 2026 target; opaque unit economics and ARPU.</li>
              <li>Europe-heavy concentration and nascent data moat.</li>
            </ul>
          </div>
          <div class="sg-box s-blue">
            <h4>Opportunities</h4>
            <ul>
              <li>Exploit ‚Ç¨8.75B Europe SAM via SME, self-employed, retiree and public sector tenders.</li>
              <li>AI underwriting and personalization (Mistral tie-ins) and expansion across EU.</li>
            </ul>
          </div>
          <div class="sg-box s-yellow">
            <h4>Threats</h4>
            <ul>
              <li>Incumbent hunting (AXA/Allianz/Generali), regulatory shifts, macro downturn affecting SME spend.</li>
              <li>Big Tech entrants and talent competition.</li>
            </ul>
          </div>
        </div>

        <h3 id="action-plan">Action plan</h3>
        <ul>
          <li><strong>Defense:</strong> Fortify European regulatory moat and product stickiness (24h claims, zero-paper optical), extend cash runway for macro resilience and data flywheel development.</li>
          <li><strong>Offense:</strong> Accelerate AI-driven underwriting and prevention to capture 3%+ SOM (~‚Ç¨262M) via SME and public sector GTM; use Series F capital for provider network M&amp;A.</li>
          <li><strong>Kill shot:</strong> Maintain profitability trajectory; avoid regulatory clampdowns and maintain founder control to prevent down-round dilution.</li>
          <li><strong>Remediation:</strong> Improve unit-economics transparency, deploy claims AI hedging, and prove ARPU/FCL improvement pre-2026.</li>
        </ul>
      </section>

      <!-- STEP 11: CONVICTION, SOURCES & FOOTER -->
      <section id="conviction">
        <h3>Conviction</h3>
        <p>Proplace GP view: High conviction in market timing and strategic fit. Alan exhibits a strong thesis fit via founder-market alignment, vertical integration, and a defensible regulatory/data moat. Timing is now ‚Äî regulatory tailwinds and SME digital adoption create a window for a dominant platform.</p>
      </section>

      <section id="sources">
        <h3>Sources &amp; Data Quality</h3>

        <h4>Value Chain Sources</h4>
        <div class="source-list">
          <p><strong>SOURCES BIBLIOGRAPHY ‚Äî Integrated Digital Health Insurance SaaS Value Chain Analysis</strong></p>
          <ol>
            <li><a href="https://www.cognitivemarketresearch.com/healthcare-saas-market-report?utm_source=openai" target="_blank">Cognitive Market Research - Healthcare SaaS</a></li>
            <li><a href="https://www.statista.com/outlook/hmo/digital-health/europe?utm_source=openai" target="_blank">Statista - Digital Health Europe</a></li>
            <li><a href="https://www.mordorintelligence.com/industry-reports/digital-insurance-platform-market?utm_source=openai" target="_blank">Mordor Intelligence - Digital Insurance Platform</a></li>
            <li><a href="https://www.marketgrowthreports.com/market-reports/health-insurance-platforms-market-119217?utm_source=openai" target="_blank">Market Growth Reports - Health Insurance Platforms</a></li>
            <li><a href="https://cfoproanalytics.com/cfo-wiki/saas/gross-margin-targets-for-saas-companies/?utm_source=openai" target="_blank">CFO Pro Analytics - SaaS Margins</a></li>
            <li><a href="https://www.gartner.com/en/documents/4012603?utm_source=openai" target="_blank">Gartner - Healthcare SaaS Pricing</a></li>
            <li><a href="https://fastercapital.com/content/Unit-economics-for-healthtech-operation--Healthy-Margins--How-Unit-Economics-Drive-HealthTech-Success.html?utm_source=openai" target="_blank">FasterCapital - Unit Economics</a></li>
            <li><a href="https://msg-insurance-suite.com/blog/rethinking-insurance/usage-based-pricing-for-saas-solutions/?utm_source=openai" target="_blank">MSG - Usage-based Pricing</a></li>
            <li><a href="https://www.wiseguyreports.com/reports/health-insurance-software-market?utm_source=openai" target="_blank">WiseGuy - Health Insurance Software</a></li>
            <li><a href="https://www.datainsightsconsultancy.com/reports/health-insurance-technology-market/?utm_source=openai" target="_blank">Data Insights Consultancy</a></li>
            <li><a href="https://en.wikipedia.org/wiki/CompuGroup_Medical?utm_source=openai" target="_blank">Wikipedia - CompuGroup Medical</a></li>
            <li><a href="https://en.wikipedia.org/wiki/Benefitalign?utm_source=openai" target="_blank">Wikipedia - Benefitalign</a></li>
            <li><a href="https://getlatka.com/companies/industries/i-health-insurance-software?utm_source=openai" target="_blank">GetLatka - Health Insurance Software</a></li>
            <li><a href="https://www.businessinsider.com/zelis-healthcare-hires-goldman-sachs-jpmorgan-early-2026-ipo-2025-10?utm_source=openai" target="_blank">Business Insider - Zelis</a></li>
            <li><a href="https://persivia.com/2026/01/07/top-8-value-based-care-platforms-in-2026-compared/?utm_source=openai" target="_blank">Persivia - Value-Based Care</a></li>
            <li><a href="https://en.wikipedia.org/wiki/Plum_%28company%29?utm_source=openai" target="_blank">Wikipedia - Plum</a></li>
            <li>Value chain queries and defensibility analysis (internal / full response texts).</li>
            <li>Defensibility query full response texts.</li>
            <li>Customer segmentation and TAM/pricing/margins queries (full response texts).</li>
            <li>Additional market & company reference material referenced in the dossier.</li>
          </ol>
          <p><em>Total Sources cited for value chain: 20</em></p>
        </div>

        <h4>Market sources</h4>
        <div class="source-list">
          <p>Key market sources used across top-down, bottom-up and trends:</p>
          <ul>
            <li><a href="https://www.mordorintelligence.com/industry-reports/digital-insurance-platform-market?utm_source=openai" target="_blank">Mordor Intelligence - Digital Insurance Platform Market</a></li>
            <li><a href="https://www.cognitivemarketresearch.com/healthcare-saas-market-report?utm_source=openai" target="_blank">Cognitive Market Research - Healthcare SaaS</a></li>
            <li><a href="https://market.us/report/digital-health-insurance-market/?utm_source=openai" target="_blank">Market.us - Digital Health Insurance Market</a></li>
            <li><a href="https://fastercapital.com/content/Unit-economics-for-healthtech-operation--Healthy-Margins--How-Unit-Economics-Drive-HealthTech-Success.html?utm_source=openai" target="_blank">FasterCapital - Unit Economics</a></li>
            <li><a href="https://www.statista.com/outlook/hmo/digital-health/europe?utm_source=openai" target="_blank">Statista - Digital Health Europe</a></li>
            <li><a href="https://www.marketgrowthreports.com/market-reports/health-insurance-platforms-market-119217?utm_source=openai" target="_blank">Market Growth Reports</a></li>
            <li><a href="https://cfoproanalytics.com/cfo-wiki/saas/gross-margin-targets-for-saas-companies/?utm_source=openai" target="_blank">CFO Pro Analytics - SaaS Margins</a></li>
            <li><a href="https://msg-insurance-suite.com/blog/rethinking-insurance/usage-based-pricing-for-saas-solutions/?utm_source=openai" target="_blank">MSG - Usage Pricing</a></li>
            <li><a href="https://www.wiseguyreports.com/reports/health-insurance-software-market?utm_source=openai" target="_blank">WiseGuy</a></li>
          </ul>
        </div>

        <h4>Company sources</h4>
        <div class="source-list">
          <p>Key company evidence used for the dossier (selected links):</p>
          <ul>
            <li><a href="https://linkedin.com/in/jcsamuelian" target="_blank">Jean-Charles Samuelian-Werve ‚Äî LinkedIn</a></li>
            <li><a href="https://www.finsmes.com/2024/09/alan-raises-e173m-in-series-f-funding.html" target="_blank">Alan Series F fundraise coverage</a></li>
            <li><a href="https://alan.com" target="_blank">Alan official website</a></li>
            <li><a href="https://techcrunch.com/2024/09/20/health-insurance-startup-alan-reaches-45-billion-valuation-with-new-funding-round/?utm_source=openai" target="_blank">TechCrunch coverage</a></li>
            <li><a href="https://techcrunch.com/2024/11/05/alan-unveils-ai-based-health-assistant-to-complement-its-health-insurance/" target="_blank">Alan AI assistant coverage</a></li>
            <li><a href="https://www.lemonde.fr/economie/article/2024/06/06/le-neo-assureur-alan-remporte-la-couverture-sante-d-au-moins-60-000-fonctionnaires_6237738_3234.html" target="_blank">Le Monde ‚Äî public sector win</a></li>
            <li><a href="https://techcrunch.com/2025/01/29/health-insurance-startup-alan-keeps-growing-at-a-rapid-pace/" target="_blank">TechCrunch ‚Äî expansion coverage</a></li>
            <li>Additional company-level evidence and internal research notes (17 URLs located / 20 searched; data completeness ~85%).</li>
          </ul>
        </div>

        <p class="final-footer" style="text-align:left;">
          Generated by <a href="https://www.proplace.co" target="_blank">Proplace</a> for Investment Criteria - alexandre@proplace.co (last update: 01.02.2026 07:08)
        </p>
      </section>

    </main>
  </div>
</body>
</html>